Respiratory and Critical Care
This reprint provides important scientific information across all areas of respiratory research including COVID-19, COPD, asthma, pulmonary embolism, pneumonia, sleep medicine and respiratory critical care.
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 05783namaa2201909uu 4500 | ||
---|---|---|---|
001 | doab96661 | ||
003 | oapen | ||
005 | 20230202 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 230202s2023 xx |||||o ||| 0|eng d | ||
020 | |a 9783036563749 | ||
020 | |a 9783036563756 | ||
020 | |a books978-3-0365-6374-9 | ||
024 | 7 | |a 10.3390/books978-3-0365-6374-9 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a KNDP |2 bicssc | |
720 | 1 | |a Pantazopoulos, Ioannis |4 edt | |
720 | 1 | |a Kotsiou, Ourania S. |4 edt | |
720 | 1 | |a Kotsiou, Ourania S. |4 oth | |
720 | 1 | |a Pantazopoulos, Ioannis |4 oth | |
245 | 0 | 0 | |a Respiratory and Critical Care |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 online resource (322 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a This reprint provides important scientific information across all areas of respiratory research including COVID-19, COPD, asthma, pulmonary embolism, pneumonia, sleep medicine and respiratory critical care. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Pharmaceutical industries |2 bicssc | |
653 | |a acute respiratory distress syndrome | ||
653 | |a adults | ||
653 | |a air pollution | ||
653 | |a anesthesiology | ||
653 | |a antibody | ||
653 | |a anticoagulant treatment | ||
653 | |a antituberculotic drugs | ||
653 | |a asthma | ||
653 | |a biomarkers | ||
653 | |a bleeding complications | ||
653 | |a breakthrough COVID-19 hospitalizations | ||
653 | |a C-reactive protein (CRP) | ||
653 | |a cardiovascular | ||
653 | |a cardiovascular dynamics | ||
653 | |a cardiovascular infections | ||
653 | |a chronic obstructive pulmonary disease | ||
653 | |a clinical outcomes | ||
653 | |a cloth masks | ||
653 | |a cognitive | ||
653 | |a cognitive impairment | ||
653 | |a community-acquired pneumonia (CAP) | ||
653 | |a control | ||
653 | |a COPD | ||
653 | |a cough | ||
653 | |a COVID-19 | ||
653 | |a critical care | ||
653 | |a D-dimers | ||
653 | |a dental effects | ||
653 | |a diagnosis | ||
653 | |a diaphragmatic thickness fraction | ||
653 | |a diffuse alveolar damage | ||
653 | |a digitalization of healthcare | ||
653 | |a dyspnea | ||
653 | |a effectiveness | ||
653 | |a emergency department | ||
653 | |a eosinophil blood count | ||
653 | |a exacerbations | ||
653 | |a exercise | ||
653 | |a expiratory muscle training | ||
653 | |a Factor VIII | ||
653 | |a FEV1 | ||
653 | |a FFP masks | ||
653 | |a fractional exhaled NO | ||
653 | |a hemodynamics | ||
653 | |a histology | ||
653 | |a hospitalization | ||
653 | |a host immune response | ||
653 | |a human | ||
653 | |a ICU admission | ||
653 | |a idiopathic pulmonary fibrosis | ||
653 | |a iloprost | ||
653 | |a immunization | ||
653 | |a in-hospital bleeding | ||
653 | |a infection | ||
653 | |a inflammation | ||
653 | |a inflammatory rheumatoid disease | ||
653 | |a influenza | ||
653 | |a inspiratory muscle training | ||
653 | |a intensive care medicine | ||
653 | |a interferon-inducible protein-10 | ||
653 | |a intubation | ||
653 | |a ischemia modified albumin | ||
653 | |a latent tuberculosis | ||
653 | |a length of stay | ||
653 | |a low muscle mass | ||
653 | |a lung aging | ||
653 | |a lung mechanics | ||
653 | |a mandibular advancement devices (MADs) | ||
653 | |a masks | ||
653 | |a mean circulatory filling pressure | ||
653 | |a mechanical ventilation | ||
653 | |a medical masks | ||
653 | |a microparticles | ||
653 | |a microRNAs | ||
653 | |a mortality | ||
653 | |a n/a | ||
653 | |a N95 masks | ||
653 | |a obstructive sleep apnea (OSA) | ||
653 | |a one-lung ventilation | ||
653 | |a open lung biopsy | ||
653 | |a outcomes | ||
653 | |a oxidative stress | ||
653 | |a oxygenation | ||
653 | |a pandemic | ||
653 | |a PM2.5 | ||
653 | |a pneumonia | ||
653 | |a prediction of bleeding | ||
653 | |a prognosis | ||
653 | |a propofol | ||
653 | |a pulmonary embolism | ||
653 | |a pulmonary fibrosis | ||
653 | |a pulmonary rehabilitation | ||
653 | |a recovery | ||
653 | |a respiratory disease | ||
653 | |a respiratory diseases | ||
653 | |a respiratory muscle training | ||
653 | |a respiratory side effects | ||
653 | |a rest volume | ||
653 | |a risk factors | ||
653 | |a sarcopenia | ||
653 | |a SARS-CoV-2 | ||
653 | |a SARS-CoV-2 IgG Spike responses | ||
653 | |a septic shock | ||
653 | |a severity | ||
653 | |a sevoflurane | ||
653 | |a skeletal effects | ||
653 | |a sleep deprivation | ||
653 | |a sputum | ||
653 | |a stressed volume | ||
653 | |a supine position | ||
653 | |a thyroidectomy | ||
653 | |a transmission | ||
653 | |a troponin | ||
653 | |a tuberculosis | ||
653 | |a unstressed volume | ||
653 | |a upper respiratory infections | ||
653 | |a urokinase plasminogen activator receptor | ||
653 | |a usTnT | ||
653 | |a vaccination | ||
653 | |a vaccine-induced immunity | ||
653 | |a venous return | ||
653 | |a venous thromboembolism | ||
653 | |a virus diseases | ||
653 | |a vitamin D | ||
653 | |a β-Thalassemia | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/96661 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6606 |7 0 |z Open Access: DOAB, download the publication |